Search
ICU Medical Inc
ICUIAdd to Watchlist
165.610USD
+4.150+2.57%
Close 07-28 16:00（ET）Quotes delayed by 15 min
4.14BMarket Cap
88.22P/E TTM
More Details of ICU Medical Inc Company
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
ICU Medical Inc Info
Ticker SymbolICUI
Company nameICU Medical Inc
IPO dateMar 31, 1992
CEOJain (Vivek)
Number of employees15000
Security typeOrdinary Share
Fiscal year-endMar 31
Address951 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92673-6212
Phone19493662183
Websitehttps://www.icumed.com/
Ticker SymbolICUI
IPO dateMar 31, 1992
CEOJain (Vivek)
Company Executives of ICU Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%
Ms. Laurie Hernandez
Ms. Laurie Hernandez
Independent Director
Independent Director
4.86K
+25.79%
Ms. Kolleen T. Kennedy
Ms. Kolleen T. Kennedy
Independent Director
Independent Director
4.54K
+27.63%
Ms. Elisha W. Finney
Ms. Elisha W. Finney
Independent Director
Independent Director
4.51K
+27.83%
Mr. John Mills
Mr. John Mills
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Vivek Jain
Mr. Vivek Jain
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
279.17K
+44.40%
Mr. Brian Michael Bonnell
Mr. Brian Michael Bonnell
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
71.75K
+57.70%
Mr. Christian B. Voigtlander
Mr. Christian B. Voigtlander
Chief Operating Officer
Chief Operating Officer
46.31K
+86.85%
Mr. Daniel (Dan) Woolson
Mr. Daniel (Dan) Woolson
President
President
22.48K
-9.44%
Mr. David C. Greenberg, J.D.
Mr. David C. Greenberg, J.D.
Lead Independent Director
Lead Independent Director
9.71K
+12.91%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
6.00K
+20.89%
FAQs
Who are the top five shareholders of ICU Medical Inc?
The top five shareholders of ICU Medical Inc are: Mr. Vivek Jain
How many institutions hold shares of ICU Medical Inc (ICUI)?
As of 2026Q1, 628 institutions hold shares of ICU Medical Inc, with a combined market value of approximately 28.59M, accounting for 114.41% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 638369.00.
What is the biggest source of revenue for ICU Medical Inc?
In 2026Q1, the Infusion Consumables business generated the highest revenue for ICU Medical Inc, amounting to 1.11B and accounting for 49.71% of total revenue.